Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumio Kataoka

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Clinical applications of ovarian cancer biomarkers]Fumio Kataoka, Daisuke Aoki
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[CA546, CA602]Hiroshi Yamashita, Fumio Kataoka, Daisuke A Aoki
Nihon Geka Gakkai Zasshi|December 24, 2013
[Transvaginal hybrid natural orifice translumenal endoscopic surgery appendectomy]Norihito Wada, Minoru Tanabe, Fumio Kataoka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Tumor markers for ovarian cancers]Daisuke Aoki, Fumio Kataoka, Nobuyuki Susumu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 4, 2005
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151Takayuki Shiomi, Isao Inoki, Fumio Kataoka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 16, 2005
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1)Ryoichi Nemori, Masayoshi Yamamoto, Fumio Kataoka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 20, 2009
Beta1,3-galactosyltransferases-4/5 are novel tumor markers for gynecological cancersAkira Seko, Fumio Kataoka, Daisuke Aoki, et al.
Glycoconjugate Journal|January 22, 2009
N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancerAkira Seko, Fumio Kataoka, Daisuke Aoki, et al.
Journal of Minimally Invasive Gynecology|July 23, 2013
Evaluation of clinical usefulness of a medical monitor equipped with an organic electroluminescence panel in comparison with liquid crystal display monitorsFumio Kataoka, Hiroyuki Nomura, Yuya Nogami, et al.
Human Pathology|January 18, 2011
Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapySadako Nishimura, Hiroshi Tsuda, Fumio Kataoka, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Clinical applications of ovarian cancer biomarkers]Fumio Kataoka, Daisuke Aoki
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2010
[CA546, CA602]Hiroshi Yamashita, Fumio Kataoka, Daisuke A Aoki
Nihon Geka Gakkai Zasshi|December 24, 2013
[Transvaginal hybrid natural orifice translumenal endoscopic surgery appendectomy]Norihito Wada, Minoru Tanabe, Fumio Kataoka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Tumor markers for ovarian cancers]Daisuke Aoki, Fumio Kataoka, Nobuyuki Susumu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 4, 2005
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151Takayuki Shiomi, Isao Inoki, Fumio Kataoka, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 16, 2005
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1)Ryoichi Nemori, Masayoshi Yamamoto, Fumio Kataoka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 20, 2009
Beta1,3-galactosyltransferases-4/5 are novel tumor markers for gynecological cancersAkira Seko, Fumio Kataoka, Daisuke Aoki, et al.
Glycoconjugate Journal|January 22, 2009
N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancerAkira Seko, Fumio Kataoka, Daisuke Aoki, et al.
Journal of Minimally Invasive Gynecology|July 23, 2013
Evaluation of clinical usefulness of a medical monitor equipped with an organic electroluminescence panel in comparison with liquid crystal display monitorsFumio Kataoka, Hiroyuki Nomura, Yuya Nogami, et al.
Human Pathology|January 18, 2011
Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapySadako Nishimura, Hiroshi Tsuda, Fumio Kataoka, et al.
Pageof 5